Advanced Renal Cell Carcinoma (aRCC)
Oncology·MeSH: Carcinoma, Renal Cell
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Advanced Renal Cell Carcinoma (aRCC)?
There are 1 clinical trial targeting Advanced Renal Cell Carcinoma (aRCC) tracked by BioSniper.
What is the prevalence of Advanced Renal Cell Carcinoma (aRCC)?
The estimated prevalence of Advanced Renal Cell Carcinoma (aRCC) is approximately 30.0 per 100,000 population.
Deep-dive into Advanced Renal Cell Carcinoma (aRCC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis